Global Slide Stainer Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Slide Stainer Market is presumed to reach the market size of nearly USD 15.41 BN by 2030 from USD 7.14 BN in 2022 with a CAGR of 8.92% under the study period 2023 - 2030.

Slide stainer is a chemical substance used for imparting stain to tissues and cells, which further assists in microscopic identification and makes cellular research easy. The slide stainer machine automates the staining of prepared cytology and histology tissue specimens by spreading dyes into the specimen by surface adsorption, direct staining, mordant staining, or indirect staining. The procedures employed in the automated slide stainer are linear transport and rotating transport.

MARKET DYNAMICS:

Slide stainer products are in huge demand due to the increasing cases of cancer, chronic illnesses, and infectious diseases. The rising geriatric population, usage of AI in histopathology, surge in cancer screening, and increasing cancer drug trials. The rapid, efficient, and high throughput features of the semi-automated and automated slide staining systems are leading to the market expansion of slide stainers. In addition, the growth in this market will be driven by the increasing number of diagnostic centers, a growing patient base, and improved healthcare infrastructure. Furthermore, technological advancements in the healthcare industry, increasing adoption of automated slide stainers, rising demand for slide stains in diagnostic facilities and clinical research, and a surge in laboratory automation procedures are factors propelling the market growth for slide stainers.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of slide stainer. The growth and trends of slide stainer industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the slide stainer market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Reagents (Stains Diluents & Buffers, Blocking Sera & Reagents, Mounting Media Fixative Reagents And Embedding Media, Probes, Antibodies)
Equipment (Automated & Semi-Automated Slide Stainer, Manual Staining Set)
Consumables & Accessories

By Technology

Hematoxylin And Eosin
Immunohistochemistry
Cytology
Microbiology
Special Stains
In-Situ Hybridization
Hematology

By Application

Disease Diagnosis (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Lung Cancer, Other Diseases)
Medical Research

By End User

Hospitals & Diagnostic Laboratories
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Slide Stainer market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the slide stainer market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Thermo Fisher Scientific, Inc. (US), Merck KGAA (Germany), Agilent Technologies, Inc. (US), Abcam Plc. (UK), Becton, Dickinson and Company (US), Siemens Healthineers AG (Germany), Biocare Medical, LLC (US), Hardy Diagnostics (US), General Data Company (US), ELITechGroup (France), Biogenex (US), Histo-Line Laboratories (Italy), SLEE medical GmbH (Germany), Amos scientific Pty Ltd. (Australia), MEDITE Medical GMBH (Germany), Cellpath Ltd (UK), Diapath S.P.A. (Italy), Bio SB, Inc. (US), Rockland Immunochemicals, Inc. (US), Cell Signaling Technology, Inc. (US), Diagnostic BioSystems, Inc. (US), and Dakewe Biotech Co., Ltd. (China). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219318

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . SLIDE STAINER - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL SLIDE STAINER MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Reagents (Stains Diluents & Buffers, Blocking Sera & Reagents, Mounting Media Fixative Reagents And Embedding Media, Probes, Antibodies) Historic and Forecast Sales by Regions
6.5 Equipment (Automated & Semi-automated Slide Stainer, Manual Staining Set) Historic and Forecast Sales by Regions
6.6 Consumables & Accessories Historic and Forecast Sales by Regions

7 . GLOBAL SLIDE STAINER MARKET ANALYSIS BY TECHNOLOGY

7.1 Overview by Technology
7.2 Historical and Forecast Data
7.3 Analysis by Technology
7.4 Hematoxylin And Eosin Historic and Forecast Sales by Regions
7.5 Immunohistochemistry Historic and Forecast Sales by Regions
7.6 Cytology Historic and Forecast Sales by Regions
7.7 Microbiology Historic and Forecast Sales by Regions
7.8 Special Stains Historic and Forecast Sales by Regions
7.9 In-situ Hybridization Historic and Forecast Sales by Regions
7.10. Hematology Historic and Forecast Sales by Regions

8 . GLOBAL SLIDE STAINER MARKET ANALYSIS BY APPLICATION

8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Disease Diagnosis (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-small Lung Cancer, Other Diseases) Historic and Forecast Sales by Regions
8.5 Medical Research Historic and Forecast Sales by Regions

9 . GLOBAL SLIDE STAINER MARKET ANALYSIS BY END USER

9.1 Overview by End User
9.2 Historical and Forecast Data
9.3 Analysis by End User
9.4 Hospitals & Diagnostic Laboratories Historic and Forecast Sales by Regions
9.5 Academic & Research Institutes Historic and Forecast Sales by Regions
9.6 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
9.7 Other End Users Historic and Forecast Sales by Regions

10 . GLOBAL SLIDE STAINER MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE SLIDE STAINER COMPANIES

11.1. Slide Stainer Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF SLIDE STAINER INDUSTRY

12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. F. Hoffmann-La Roche Ltd. (SwitzerlAnd)
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Danaher Corporation (US)
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. PHC Holdings Corporation (Japan)
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Thermo Fisher Scientific Inc. (US)
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Merck KGAA (Germany)
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Agilent Technologies Inc. (US)
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Abcam Plc. (UK)
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Becton
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. Dickinson And Company (US)
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. Siemens Healthineers AG (Germany)
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Biocare Medical LLC (US)
- 12.13.1. Company Overview
- 12.13.2. Company Revenue
- 12.13.3. Products
- 12.13.4. Recent Developments
12.14. Hardy Diagnostics (US)
- 12.14.1. Company Overview
- 12.14.2. Company Revenue
- 12.14.3. Products
- 12.14.4. Recent Developments
12.15. General Data Company (US)
- 12.15.1. Company Overview
- 12.15.2. Company Revenue
- 12.15.3. Products
- 12.15.4. Recent Developments
12.16. ELITechGroup (France)
- 12.16.1. Company Overview
- 12.16.2. Company Revenue
- 12.16.3. Products
- 12.16.4. Recent Developments
12.17. Biogenex (US)
- 12.17.1. Company Overview
- 12.17.2. Company Revenue
- 12.17.3. Products
- 12.17.4. Recent Developments
12.18. Histo-Line Laboratories (Italy)
- 12.18.1. Company Overview
- 12.18.2. Company Revenue
- 12.18.3. Products
- 12.18.4. Recent Developments
12.19. SLEE medical GmbH (Germany)
- 12.19.1. Company Overview
- 12.19.2. Company Revenue
- 12.19.3. Products
- 12.19.4. Recent Developments
12.20. Amos scientific Pty Ltd. (Australia)
- 12.20.1. Company Overview
- 12.20.2. Company Revenue
- 12.20.3. Products
- 12.20.4. Recent Developments
12.21. MEDITE Medical GMBH (Germany)
- 12.21.1. Company Overview
- 12.21.2. Company Revenue
- 12.21.3. Products
- 12.21.4. Recent Developments
12.22. Cellpath Ltd (UK)
- 12.22.1. Company Overview
- 12.22.2. Company Revenue
- 12.22.3. Products
- 12.22.4. Recent Developments
12.23. Diapath S.P.A. (Italy)
- 12.23.1. Company Overview
- 12.23.2. Company Revenue
- 12.23.3. Products
- 12.23.4. Recent Developments
12.24. Bio SB Inc. (US)
- 12.24.1. Company Overview
- 12.24.2. Company Revenue
- 12.24.3. Products
- 12.24.4. Recent Developments
12.25. Rockland Immunochemicals Inc. (US)
- 12.25.1. Company Overview
- 12.25.2. Company Revenue
- 12.25.3. Products
- 12.25.4. Recent Developments
12.26. Cell Signaling Technology Inc. (US)
- 12.26.1. Company Overview
- 12.26.2. Company Revenue
- 12.26.3. Products
- 12.26.4. Recent Developments
12.27. Diagnostic BioSystems Inc. (US)
- 12.27.1. Company Overview
- 12.27.2. Company Revenue
- 12.27.3. Products
- 12.27.4. Recent Developments
12.28. Dakewe Biotech Co. Ltd. (China)
- 12.28.1. Company Overview
- 12.28.2. Company Revenue
- 12.28.3. Products
- 12.28.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies